Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STAAR SURGICAL COSTAA · Entity 4851 | Director | June 18, 2026 | June 22, 2026 |
| WATERS CORP /DE/WAT · Entity 3080 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STAAR SURGICAL CO
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,127 |
Reported balance
After 2026-06-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-18 · Exercise / conversion · Acquired 10,683 · Balance 77,127 F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-18 · Exercise / conversion · Disposed 10,683 · Balance 0 F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 6,182 |
Reported balance
After 2026-06-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-18 · Grant · Acquired 6,182 · Balance 6,182 F2: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.
F2: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.
WATERS CORP /DE/
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,630.16 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 57.41 · Balance 3,630.16 F1: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2021 Filed Jul 15, 2021 20:40 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 147 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022013 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147 F1 · shares: These Restricted Stock Units vest 20% per annum for a five year period beginning on July 14, 2022. Read SEC document |
| July 14, 2021 Filed Jul 19, 2021 13:43 UTC Amendment | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 537 | $371.64 Strike: $371.64 | $199,570.68 |
DisclosureSEC source: 0001127602-21-022158 · form4a.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537 Underlying: Common Stock · 537 shares Expires 2031-07-14 F1 · shares: Amended filing reflects correct vesting schedule. F3 · shares: Options fully vest on July 14, 2022. Read SEC document |
| July 14, 2021 Filed Jul 19, 2021 13:43 UTC Amendment | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 147 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022158 · form4a.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147 F1 · shares: Amended filing reflects correct vesting schedule. F2 · shares: Grant of shares of common stock subject to restrictions that lapse July 14, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.